Product category

Pharmaceutical Chemicals API (267)

Showing 73–84 of 267 products · Page 7 of 23

Diclazuril
Veterinary Medicine API

Diclazuril

CAS 101831-37-2

As a kind of new-type, Diclazuril is a kind of high-efficiency and low-toxicity anti-coccidiosis additive. Diclazuril is widely used for chicken coccidiosis disease. It can reach the peak effect on coccidiosis. It has reliable destroying and inhibiting effect to all kinds of coccidial.

Diclofenac Sodium
Antibiotic Drugs API

Diclofenac Sodium

CAS 15307-79-6

Diclofenac sodium is a nonsteroidal anti-inflammatory drug (NSAID) which is primarily used to help treat the symptoms of arthritis. These medications can help reduce the swelling and inflammation caused by the disease to help provide comfort to the patient.

Dihydroavermectin B1a
Pharmaceutical Intermediates

Dihydroavermectin B1a

CAS 70161-11-4

Contact MOSINTER for product specifications and supply information.

Dimetridazole
Veterinary Medicine API

Dimetridazole

CAS 551-92-8

Dimetridazole is a drug that combats protozoan infections. It is a nitroimidazole class drug. Dimetridazole is a protozoan such as trichomonas, trichomonas vaginalis, colonic pouch, and flagellate, and bacteria such as Neisseria arrhythmias, Clostridium, Staphylococcus aureus, Vibrio cholerae, and Treponema pallidum. It has a significant inhibitory effect and is an effective drug for the treatment of turkey blackhead disease and pig red peony. Dimetridazole can also be used as a growth promoter to promote pig and chicken production and increase feed conversion. When dimetridazole is used as a feed additive, the product is first premixed with 10-20 times the feed amount during feed processing, and then uniformly mixed with the total amount of feed required. Or first mix dimetridazole with an appropriate amount of carrier, then add to the feed and stir. Granulation and other processes have no effect on the efficacy of this product when processing compound feed. Dimetridazole can be mixed into the feed, or added to drinking water for drinking by livestock and poultry.

Diphenylacetonitrile
Pharmaceutical Intermediates

Diphenylacetonitrile

CAS 86-29-3

Diphenylacetonitrile undergoes anhydrous condensation with ethyl-4-bromo-butyrate. This is followed by its hydrolysis in alkaline medium that is used in the quantitative determination of 3-cyano-3,3-diphenylpropionic acid.

Docetaxel
Antineoplastic Drugs API

Docetaxel

CAS 114977-28-5

Docetaxel is a kind of Taxus drug. It can promote the assembly of microtubule dimer into microtubule, stabilize microtubule by preventing the depolymerization process, block cells at G2 and M stages, and inhibit the mitosis and proliferation of cancer cells. Docetaxel has a stronger pharmacological effect than paclitaxel, a concentration three times higher than paclitaxel in the cell, and a longer retention time in the cell, and its affinity to microtubule is two times higher than Paclitaxel; as a microtubule stabilizer and assembly accelerator, its activity is two times higher than Paclitaxel; as a microtubule depolymerization inhibitor, its activity is two times higher than paclitaxel. The antitumor activity of docetaxel was 1.3-12 times that of paclitaxel in vitro. Clinical studies show that docetaxel is more effective than paclitaxel in anthracycline resistant breast cancer. Docetaxel is the most effective drug in the second-line treatment of anthracycline resistant breast cancer; in the single drug treatment and combined chemotherapy of non-small cell lung cancer, docetaxel is one of the most effective drugs.

Donepezil Hydrochloride
Psychotropic Drugs API

Donepezil Hydrochloride

CAS 110119-84-1

Donepezil hydrochloride is a kind of medicine to treat alzheimer, and is the second generation of ChE inhibitors. Comparing with other medicine, donepezil hydrochloride has a low incidence of adverse reactions, and the characteristics of curative effect is obvious.Is is the only drug that reach the FDA's alzheimer treatment guidelines standards, and is the only kind of new medicine approved both by the FDA and MCA at the same time to treat mild or moderate alzheimer.Donepezil hydrochloride can enhance the function of cholinergic.

Doramapimod
Antineoplastic Drugs API

Doramapimod

CAS 285983-48-4

It is a pyrazole-based allosteric inhibitor of p38 MAP Kinase with a Kd of 0.1 nM. BIRB796 has slow binding kinetics, as evidenced by an marked increase in apparent IC50 after preincubation periods up to 2h, as well as dissociation rates of up to six orders of magnitude greater when compared to other MAPK inhibitors. BIRB796 possesses an excellent selectivity profile over a panel of relevant kinases, with the most active being inhibition of JNK2a2 at 100 nM (330-fold selectivity).Related studies have shown that BIRB796 also inhibits activity and activation of SAPK3/p38g (3% remaining activity at 10 uM). At these concentrations, BIRB796 blocks stress-induced phosphorylation of scaffold protein SAP97.

Dorzolomide Hydrochloride
Antibiotic Drugs API

Dorzolomide Hydrochloride

CAS 130693-82-2

Dorzolamide hydrochloride is used to lower increased intraocular pressure in open-angle glaucoma and ocular hypertension.

Dovitinib
Antineoplastic Drugs API

Dovitinib

CAS 915769-50-5

Dowetinib is an effective small molecule and multi-target tyrosine kinase inhibitor, which can directly act on tumor cells and provide nutritional support for tumor cells. It can inhibit a variety of growth factors, such as vegfr1-3, fgfr1-3, PDGFRb, E-kit, RET, TRAA and CSF-1. At present, dowetinib is in the third phase of clinical research, which shows that it has obvious therapeutic effect on breast cancer, urinary tract cell cancer, prostate cancer, multiple myeloma and melanoma. With the deepening of clinical research, it is expected to expand the scope of tumor treatment.

Doxifluridine
Antineoplastic Drugs API

Doxifluridine

CAS 3094-09-5

Deoxyfluorouracil is a kind of fluorouracil derivatives, which is converted from the high activity pyrimidine nucleoside phosphorylase in tumor tissue to 5-Fu, and plays its selective anti-tumor role. The test shows that the therapeutic index of deoxyfluuridine is higher than that of 5-FU. As a precursor drug, deoxyfluuridine has better targeting, so it has better therapeutic effect and lower side effects in clinical, which has significant clinical significance for increasing the compliance of patients.

Doxorubicin Hydrochloride
Antineoplastic Drugs API

Doxorubicin Hydrochloride

CAS 25316-40-9

Doxorubicin Hydrochloride CAS 25316-40-9

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP